Richard J Rodgers
CIK 1313397 · Interim CEO and President · last filed 2026-04-22
Richard J Rodgers is an Interim CEO and President who has filed 54 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for OCUP, was dated Apr 22, 2026. Current disclosed insider exposure totals $2.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.37M
7
54
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Opus Genetics, Inc. (OCUP) Delisted | Director | 343,022 | $1.17 | $401.3K | $0 | 19 | 2026-04-22 |
| NVAX | Director | 28,490 | $8.88 | $253.0K | $0 | 8 | 2025-10-30 |
| ARDX | Director | 371,992 | $5.69 | $2.12M | $0 | 12 | 2025-06-23 |
| SGMT | Director | — | $6.48 | — | $0 | 1 | 2023-07-20 |
| Opus Genetics, Inc. (RNN) Delisted | Director | — | — | — | $0 | 6 | 2019-06-07 |
| TESARO, Inc. (TSRO) Delisted | Executive VP & CFO | 257,141 | — | — | $0 | 2 | 2013-03-08 |
| MGI PHARMA INC (MOGN) Delisted | Sr. VP & Controller | 4,474 | — | — | $0 | 4 | 2008-01-24 |
Recent Filings
54 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-22 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +24,367 | $0 | EDGAR |
| 2025-10-30 | NVAX | Exer (M) | +3,800 | $0 | EDGAR |
| 2025-06-24 | NVAX | Grant (A) | — | $0 | EDGAR |
| 2025-06-23 | ARDX | Grant (A) | +63,019 | $0 | EDGAR |
| 2025-06-13 | NVAX | Exer (M) | +10,420 | $0 | EDGAR |
| 2025-05-02 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +79,504 | $0 | EDGAR |
| 2025-01-17 | ARDX | Exer (M) | +100,000 | $55.0K | EDGAR |
| 2025-01-02 | NVAX | Exer (M) | +3,800 | $0 | EDGAR |
| 2024-06-17 | ARDX | Grant (A) | +12,204 | $0 | EDGAR |
| 2024-06-14 | NVAX | Mixed | +6,670 | $0 | EDGAR |